Mona Nemer

Mona Nemer is a Lebanese-Canadian molecular biologist and senior government official renowned for her pioneering research in cardiac development and genetics. She has held prominent academic positions at institutions like the University of Ottawa and served as the inaugural Chief Science Advisor of Canada to the Prime Minister. Her distinguished career is marked by significant contributions to understanding the molecular basis of congenital heart disease and a strong advocacy for evidence-based policy in government.

Early life and education

Born in Beirut, Lebanon, she developed an early interest in the sciences before moving to North America for her higher education. She completed a Bachelor of Science in chemistry at the American University of Beirut before immigrating to Canada. She then earned a PhD in organic chemistry from McGill University in Montreal, followed by pivotal postdoctoral research in molecular biology at the Baylor College of Medicine in Texas.

Scientific career

Following her postdoctoral work, she joined the Clinical Research Institute of Montreal as a principal investigator, establishing her independent research program. She later held a prestigious professorship in the Department of Pharmacology at the University of Montreal. In 2006, she accepted a position as Vice-President, Research at the University of Ottawa, where she also served as a professor in the Faculty of Medicine. Her leadership there significantly advanced the university's research enterprise and its collaborations with institutions like the Ottawa Hospital Research Institute.

Chief Science Advisor of Canada

In 2017, she was appointed by Prime Minister Justin Trudeau as the inaugural Chief Science Advisor of Canada, a role created to restore the voice of science within the federal government. In this capacity, she reported directly to the Prime Minister and the Minister of Innovation, Science and Industry, providing independent advice on a wide range of issues from public health to climate change. She played a critical role during the COVID-19 pandemic in Canada, advising on the scientific response and emphasizing transparency in government science.

Research and contributions

Her laboratory has made seminal discoveries in the field of cardiovascular biology, particularly focusing on the transcription factors that regulate heart formation. Her team identified key genes, such as Nkx2-5 and GATA4, that are essential for proper cardiac embryogenesis and whose mutations are linked to human congenital heart defects. This work has provided fundamental insights into the etiology of heart disease and has implications for potential therapeutic strategies. Her research has been published in leading journals including Nature, Science, and Cell.

Awards and recognition

Her scientific and leadership contributions have been recognized with numerous national and international honors. She is a Fellow of the Royal Society of Canada and was appointed a Member of the Order of Canada. She has received the Prix du Québec in the Marie-Victorin category, one of Quebec's highest scientific distinctions. Other accolades include the Canadian Institutes of Health Research Gold Key Award and honorary doctorates from several universities, including the University of Sherbrooke and Concordia University.

Category:Canadian molecular biologists Category:Chief Science Advisor of Canada Category:Members of the Order of Canada Category:Living people Category:1957 births